Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Comparing Symbicort 'as Needed' With Pulmicort Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma

NCT02224157 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02224157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02224157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Comparing Symbicort 'as Needed' With Pulmicort Twice Daily Plus Terbutaline 'as Needed' in Adult and Adolescent Patients With Asthma
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
November 28, 2014
Completion date
August 16, 2017
Enrollment
4,215 (actual)
Sites
340

Conditions

As the registry lists them; a condition with its own page is linked.

asthma